It hasreceived reports of non-serious side effects such as hives, dizziness, feverand shortness of breath in that age group, it added in a safety update on January19.
Since the COVID-19vaccination programme was rolled out for children aged 5-11 on December 27last year, six non-serious reports have been logged for this age group,equivalent to 0.03 percent out of 20,327 administered doses.
HSAreceived 1,170 side effect reports associated with the use of mRNA vaccines inadolescents aged 12-18, out of 663,239 administered doses. This makes up0.18 percent of doses administered.
HSA addedthat over 11.49 million doses of Pfizer-BioNTech/Comirnaty andModerna/Spikevax mRNA vaccines were administered between December 30, 2020 andDecember 31 last year, out of which 14,729 suspected side effect reports werereceived. Among those reports, 747 were classified as serious side effects,0.007 percent of doses administered.
There arecurrently no reports of anaphylaxis from the booster doses./.